NC-stat DPNCheck is a quantitative point-of-care test used to detect diabetic neuropathy at an early stage.
Handok expects to use both direct and indirect sales channels to promote the point-of-care test.
Handok CEO Young-jin Kim said, "As a company that values innovation in health care, we are pleased to have the opportunity to bring the diagnostic capabilities NC-stat DPNCheck to the Korea market."
NeuroMetrix president and chief executive officer Shai Gozani said, "The Korea market is important to this initiative, and we hope to further expand our presence in these large and important markets over the coming months."